Background: Neonatal respiratory care includes oxygen therapy, which is more common due to the improved survival rates of premature infants. Considering that most current studies demonstrate that preterm newborns benefit most from oxygen saturations (SpO2) of 91-95 percent, which reduces the risk of complications such as retinopathy of prematurity, we set out to study oxygen treatment and its risks in premature neonates. Objective: The reviews article highlight oxygen therapy and their risk in the premature neonates.
Conclusion:There have been improvements in outcomes for babies with extremely low birth weight when using a larger goal range (85%-93%), but these ranges have not been thoroughly assessed in major clinical trials; additional data is required. High oxygen levels may be avoided with early use of a pulmonary vasodilator.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.